Email Updates

Search form

You are here

HIV Therapeutic Vaccine Enhances Non-Exhausted CD4+ T Cells in a Randomised Phase 2 Trial

Include in
Published Research

Our findings regarding the increase of non-exhausted CD4+ T cells have potentially important application in personalised HIV vaccination for HIV-infected patients with high level of PD-1 to improve their T-cell immune function.

June 3, 2019
npj Vaccines